Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy

被引：70

作者：

Dwarakanath, B. S. ^{[1
]}

Jain, Viney ^{[2
]}

机构：

[1] Inst Nucl Med & Allied Sci, Delhi 110054, India

[2] Ecodev Fdn, New Delhi 110001, India

来源：

FUTURE ONCOLOGY | 2009年 / 5卷 / 05期

关键词：

HUMAN CEREBRAL GLIOMAS; EHRLICH ASCITES TUMOR; RADIATION RESPONSE; DRUG-RESISTANCE; CLINICAL-TRIALS; CELL-LINE; RADIOSENSITIZATION; 2-DEOXYGLUCOSE; RADIOTHERAPY; INHIBITION;

D O I：

10.2217/FON.09.44

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：581 / 585

页数：5

共 45 条

[1]

Aft RL, 2003, CANCER RES, V63, P5496

[2] 2-deoxy-D-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis [J].

Bell, SE ;

Quinn, DM ;

Kellett, GL ;

Warr, JR .

BRITISH JOURNAL OF CANCER, 1998, 78 (11) :1464-1470

[3]

BROWN J, 1962, METABOLISM, V11, P1098

[4] Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia [J].

Cao, Xianhua ;

Fang, Lanyan ;

Gibbs, Seth ;

Huang, Ying ;

Dai, Zunyan ;

Wen, Ping ;

Zheng, Xincheng ;

Sadee, Wolfgang ;

Sun, Duxin .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (04) :495-505

[5] Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors [J].

Di Cosimo, S ;

Ferretti, G ;

Papaldo, P ;

Carlini, P ;

Fabi, A ;

Cognetti, F .

DRUGS OF TODAY, 2003, 39 (03) :157-173

[6]

DIAOLA RS, 2008, PROSTATE, V68, P1743

[7]

Dwarakanath B. S., 1999, Indian Journal of Experimental Biology, V37, P865

[8] Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells [J].

Dwarakanath, BS ;

Adhikari, JS ;

Jain, V .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (05) :1125-1133

[9]

DWARAKANATH BS, 2001, INT J RADIAT ONCOL, V51, P1151

[10]

Dwarakanath BS, 2005, BIOMEDICINE, V24, P36

← 1 2 3 4 5 →